Skip to main content
Premium Trial:

Request an Annual Quote

Lion VP Joins Xantos; Illumina Hires ABI 3700 Marketer; and others

NEW YORK, Oct. 2-The Indiana Proteomics Consortium said today that it has hired Brent Boeckmann as vice president of business development.


Boeckmann will work to bring proteomic discovery tools to market through standalone ventures and partnerships.


He was previously in investment banking with Anderson Worldwide, where he lead teams advising companies in medical imaging, genetics, biotechnology, and crop sciences, among other fields. He managed venture capital attraction, asset acquisition, product licensing, investor relations and regulatory compliance.


The consortium, a collaboration between Indiana University, Purdue and Eli Lilly, seeks to develop and commercialize new proteomics tools.



Orchid BioSciences hired Andrew Savadelis as chief financial officer and senior vice president of finance, the company said today.


He replaces Donald Marvin, who previously served as both CFO and as general manager of Orchid Diagnostics. Marvin will now focus entirely on the diagnostics division.


Savadelis was most recently principal of Stratus Photonics, which develops optical signal conditioning and routing modules.



Perlegen Sciences has hired Paul Cusenza as vice president of alliance management, the company said yesterday.


Cusenza advised Perlegen prior to its independence from Affymetrix. He was previously at Capital One Financial as managing director of value added alliances and vice president of marketing and analysis.


Perlegen, based in Mountain View, Calif., is developing a rapid chip-based system for DNA analysis.



Applied Biosystems' Susan Eddins has joined Illumina as head of worldwide marketing, the company said yesterday.


She will lead marketing of the company's BeadArray and Oligator platforms and services.


Eddins was previously director of genomic assays at ABI, where she commercialized genotyping, gene expression assay, and custom oligonucleotide services. She also led product management and strategic marketing for the 3700 DNA Analyzer.


Illumina is based in San Diego, Calif.


Germany's Xantos Biomedicine said yesterday that it has hired David Chilvers as chief business officer. He will lead the company's daily business operations.


He was previously vice president for sales and marketing at Lion Biosciences.


Xantos also said that Paul Nicholson will assume the role of board chair from Peter Reinisch, who becomes vice-chair.



Tripos has hired two new vice presidents in sales and marketing, the company said yesterday.


Elizabeth Holbrook will be the informatics company's new vice president of sales and will lead account management, customer development, and sales force training in North America. She was previously in sales management at Affymetrix and at Ciphergen.


Deepak Thakkar has joined as vice president of marketing. He was previously senior director of marketing at Silicon Genetics, which provides informatics software for genetic and protein research. 


Tripos sells software products, consulting services and research services to drug discovery, agricultural research and biotech companies. It is based in St. Louis, Mo.



Rubicon Genomics said yesterday that Teri Willey had joined its board of directors. Willey is managing partner of ARCH Development Partners, which lead a recently completed round of financing that raised $3.5 million for the company.



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at ///issues/6_7/features/118311-1.html"

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.